LBA67 A phase III, randomized study of atezolizumab plus bevacizumab and chemotherapy in patients with EGFR or ALK mutated in non-small cell lung cancer (ATTLAS, KCSG-LU19-04)

Authors:
  • MAM-J. Ahn
    M-J. Ahn
  • SPS. Park
    S. Park
  • TKT.M. Kim
    T.M. Kim
  • JHJ-Y. Han
    J-Y. Han
  • GLG-W. Lee
    G-W. Lee
  • BSB. Shim
    B. Shim
  • YLY-G. Lee
    Y-G. Lee
  • SKS-W. Kim
    S-W. Kim
  • IKI-H. Kim
    I-H. Kim
  • SLS. Lee
    S. Lee
  • YKY.J. Kim
    Y.J. Kim
  • JPJ.H. Park
    J.H. Park
Publisher website
Google Scholar
Abstract
No abstract available